Nuclear Medicine: Publications
2008
Piert M, Carey J, Clinthorne N: Probe-Guided Localisation of Cancer Deposits Using [18F]FDG. Q J Nucl Med Mol Imaging 2008 Mar;52(1):37-49.
2007
*Alvarez R, Diehl KM, Avram A, Brown R, Piert M: Localisation of splenosis using (99m)Tc-damaged red blood cell SPECT/CT and intraoperative gamma probe measurements. Eur J Nucl Med 2007;34:969.
Beck R, Röper B, Carlsen JM, Huisman MC, Lebschi JA, Andratschke N, Picchio M, Souvatzoglou M, Machulla H-J, Piert M: Pretreatment [18F]FAZA PET predicts success of hypoxia-directed ra-diochemotherapy using tirapazamine. J Nucl Med 2007; Jun;48(6):973-80.
Greenwald MK, Johanson CE, Moody DE, Bueller JA, Kilbourn MR, Koeppe RA, Zubieta JK: Buprenorphine duration of action: Mu-opioid receptor availability and pharmacokinetic and behavioral indices. Biol Psychiatry 2007; 61:101-110.
Langenecker SA, Caveney AF, Giordani B, Young EA, Nielson KA, Rapport LJ, Bieliauskas LA, Mordhorst M, Marcus S, Yodkovik N, Kerber K, Berent S, Zubieta JK: The sensitivity and psychometric properties of a brief computer-based cognitive screening battery in a depression clinic. Psychiatry Res. 2007 Aug 30;152(2-3):143-54.
Langenecker SA, Kennedy SE, Guidotti LM. Anderson EM, Hooven T, Young EA, Akil H, Noll DC, Zubieta JK: Frontal and limbic activation during inhibitory control predicts treatment response in Major Depressive Disorder. Biol Psychiatry. 2007 Dec 1;62(11):1272-80.
Langenecker SA, Zubieta JK, Young EA, Akil H, Nielson KA: A task to manipulate attentional load, set-shifting and inhibitory control: Convergent validity and test-retest reliability of the parametric go/no-go test. J Clin Exp Neuropsychol. 2007 Nov;29(8):842-53.
Liberzon I, Taylor SF, Phan KL, Britton JC, Fig LM, Bueller JA, Koeppe RA, Zubieta JK: Altered central µ-opioid receptor binding following psychological trauma. Biol Psychiatry 2007; 61:1030-1038
Mody RJ, *Bui C, Hutchinson RJ, Frey KA, Shulkin BL: Comparison of [18F]FDG-PET with Ga-67 Scintigraphy and conventional imaging modalities in pediatric lymphoma. Leuk Lymphoma. 2007; 48:699-707
Piert M, Burian M, Meisetschläger G, Stein H.J, Ziegler S, Nährig J, Picchio M, Buck A, Siewert JR, Schwaiger M: Positron detection for the intraoperative localisation of cancer deposits. Eur J Nucl Med 2007 Oct;34(10):1534-44.
Scott DJ, Domino EF, Heitzeg MM, Koeppe RA, Ni L, Guthrie S, Zubieta JK: Smoking modulation of µ-opioid and dopamine D2 receptor mediated neurotransmission in humans. Neuropsychopharmacol 2007; 32: 450-457.
Scott DJ, Stohler CS, Koeppe R, Zubieta JK: Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a non-pharmacological challenge. Synapse 2007 Sep;61(9):707-14
Souvatzoglou M, Grosu A, Roeper B, Krause BJ, Beck R, Reischl G, Picchio M, Machulla H-J, Piert M: Tumour hypoxia imaging with [18F]FAZA PET in head & neck cancer patients: A pilot study. Eur J Nucl Med Mol Imaging. 2007 Oct; 34(10):1566-75.
Wager TD, Scott DJ, Zubieta JK: Placebo effects on human µ-opioid activity during pain. Proc Natl Acad Sci USA. 2007 Jun 26;104(26):11056-61.
2006
Raffel DM, Chen W, Sherman P, Gildersleeve DL, Jung YW. Dependence of cardiac [11C]meta-hydroxyephedrine retention on cardiac NET density. J Nucl Med 2006 Sep;47(9):1490-6.
Avram AM, Fig LM, Gross MD: Adrenal gland scintigraphy. Semin Nucl Med. 2006; 36:212-227.
Avram AM, *Mackie GC, Schneider BJ, Kalemkerian GP, Shulkin BL. Differentiation between carcinoid and sarcoid with 18F FDG PET and 111In-pentreteotide. Clin Nucl Med. 2006; 31:197-200.
Bohnen NI, Albin RL, Koeppe RA, Wernette K, Kilbourn MR, Minoshima S, Frey KA: Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab 2006; 26:1198-1212.
Bohnen N, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM, Mathis CA, Davis JG, Moore RY, DeKosky ST: Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia. J Neurol 2006; 253:242-247.
Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK: BDNF val66met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 2006; 59:812-815.
Frey KA, Albin RL. NeuroImaging of Tourette Syndrome. J Child Neurol 2006; 21:672-677.
Johansen C-E, Frey KA, Lundahl L, Keenan P, Lockhart N, Roll J, Galloway G, Koeppe RA, Kilbourn MR, Robbins T, Schuster CR: Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology (Berl). 2006; 185:327-338.
Kennedy SM, Koeppe RA, Young, EA, Zubieta JK: Dysregulation of endogenous opioid, emotion regulation circuitry in Major Depression. Arch Gen Psychiatry 2006; 63:1199-1208.
Krause BJ, Beck R, Souvatzoglou M, Piert M: PET and PET/CT studies of tumor tissue oxygenation. Q J Nucl Med Mol Imaging. 2006; 50:28-43.
Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR: In vivo butyrylcholinesterase activity is not increased in Alzheimer synapses. Ann Neurol 2006; 59:13-20.
Marshall GA, Hendrickson R, Kaufer DI, Ivanco LS, Bohnen NI: Cognitive correlates of brain MRI subcortical signal hyperintensities in non-demented elderly. Int J Geriatr Psychiatry 2006; 21:32-35.
Marshall GA, Shchelchkov E, Kaufer DI, Ivanco LS, Bohnen NI: White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia. Acta Neurol Scand 2006; 113:87-91.
Mink JW, Walkup J, Frey KA, Como P, Cath D, DeLong MR, Erenberg G, Jankovic J, Juncos J, Leckman JF, Swerdlow N, Visser-Vandewalle V, Vitek JL for the Tourette Syndrome Association, Inc. Patient Selection and Assessment Recommendations for Deep Brain Stimulation in Tourette Syndrome. Mov Disord 2006; 21:1831-1838.
Newman EA, Cimmino VM, Sabel MS, Diehl KM, Frey KA, Chang AE, Newman LA: Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol 2006; 13:1-6.
Picchio M, Treiber U, Beer AJ, Metz S, Bossner P, van Randenborgh H, Paul R, Weirich G, Sou-vatzoglou M, Hartung R, Schwaiger M, Piert M: Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med. 2006; 47:938-944.
Scott DJ, Heitzeg MM, Koeppe RA, Stohler CS, Zubieta JK: Variations in the human pain stress experience medicated by ventral and dorsal basal ganglia activity. J Neurosci 2006; 26:10789-10795.
Smith YR, Love T, Persad CC, Tkaczyk A, Zubieta JK: Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J Clin Endocrinol Metab 2006; 91:4476-4481.
Smith YR, Stohler CS, Nichols TE, Bueller JA, Xu Y, Koeppe RA, Zubieta JK: Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci 2006; 26: 5777-5785.
Sisson JC, Avram AM, Lawson SA, Gauger PG, Doherty GM. On the So-Called Stunning of Thyroid Tissue. J Nucl Med 2006; 47:1406-1412.
Zubieta JK, Yau WY, Scott DJ, Stohler CS: Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect. Brain Behav Immu 2006; 20:15-26.
